Vij, Ravi <br/><br/>
Donor CMV serostatus has no impact on CMV viremia or disease when prophylactic granulocyte transfusions are given following allogeneic peripheral blood stem cell transplantation.  [electronic resource] 

 -  Blood  Mar 2003 
 - 2067-9 p.  digital 
<br/><br/> Publication Type: Comparative Study; Journal Article 
<br/><br/><label>ISSN: </label>0006-4971 
<br/><br/><label>Standard No.: </label>10.1182/blood-2002-07-2110  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adolescent<br/>Adult<br/>Aged<br/>Cohort Studies<br/>Cytomegalovirus--physiology<br/>Cytomegalovirus Infections--epidemiology<br/>Female<br/>Graft vs Host Disease--epidemiology<br/>Granulocyte Colony-Stimulating Factor--pharmacology<br/>Granulocytes--transplantation<br/>Hematologic Neoplasms--therapy<br/>Humans<br/>Incidence<br/>Leukocyte Transfusion--adverse effects<br/>Male<br/>Middle Aged<br/>Neutropenia--etiology<br/>Peripheral Blood Stem Cell Transplantation--adverse effects<br/>Prospective Studies<br/>Random Allocation<br/>Safety<br/>Tissue Donors<br/>Transplantation Conditioning<br/>Transplantation, Homologous<br/>Viremia--epidemiology